Technion researchers cure mice of diabetes in novel trial | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Technion researchers cure mice of diabetes in novel trial

A team of researchers at the Technion-Israel Institute of Science have used genetically engineered muscle tissue to cure mice of type 2 diabetes, according to a report published in the peer-reviewed journal Science Advances.

Muscle cells are among the main targets of insulin, and they are supposed to absorb sugar from the blood. However, in type 2 diabetics, the ability of these cells to absorb sugar is reduced.

Restoring the metabolic activity of skeletal muscle could therefore provide a cure for the disease. But, until now, it has been an unexplored optional therapy.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA